Annabel Acs

2.9k total citations · 1 hit paper
10 papers, 1.8k citations indexed

About

Annabel Acs is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Annabel Acs has authored 10 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Cardiology and Cardiovascular Medicine and 1 paper in Molecular Biology. Recurrent topics in Annabel Acs's work include Diabetes Treatment and Management (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cardiovascular Function and Risk Factors (2 papers). Annabel Acs is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cardiovascular Function and Risk Factors (2 papers). Annabel Acs collaborates with scholars based in Canada, United States and Denmark. Annabel Acs's co-authors include Thomas R. Einarson, Ulrik Haagen Panton, Michael Tutty, Jane Snowdon, Kyu Rhee, Kelly Jean Thomas Craig, Talia Boulanger, Christine A. Sinsky, Abayomi Ogundele and Yang Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Value in Health and Cardiovascular Diabetology.

In The Last Decade

Annabel Acs

8 papers receiving 1.8k citations

Hit Papers

Prevalence of cardiovascular disease in type 2 diabetes: ... 2018 2026 2020 2023 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017
    2018 1.4k citations Thomas R. Einarson, Annabel Acs et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annabel Acs Canada 7 916 459 391 288 275 10 1.8k
Ulrik Haagen Panton Denmark 9 971 1.1× 473 1.0× 405 1.0× 312 1.1× 297 1.1× 17 1.8k
Frank Schäper Germany 25 765 0.8× 520 1.1× 394 1.0× 319 1.1× 221 0.8× 52 1.9k
Sandra Pinho Silveiro Brazil 24 965 1.1× 412 0.9× 443 1.1× 515 1.8× 300 1.1× 91 3.0k
Dong Zhao China 24 606 0.7× 492 1.1× 446 1.1× 437 1.5× 347 1.3× 147 2.3k
Dudan Zhang China 7 716 0.8× 305 0.7× 295 0.8× 195 0.7× 391 1.4× 9 1.6k
Angelyne Amos Australia 5 969 1.1× 233 0.5× 293 0.7× 225 0.8× 339 1.2× 7 1.8k
Chul Sik Kim South Korea 25 661 0.7× 230 0.5× 476 1.2× 289 1.0× 256 0.9× 97 1.6k
György Jermendy Hungary 26 1.1k 1.2× 530 1.2× 471 1.2× 391 1.4× 229 0.8× 151 2.1k
Eric S. H. Lau Hong Kong 26 1.2k 1.3× 282 0.6× 389 1.0× 323 1.1× 424 1.5× 109 2.2k
Ken Gu Singapore 9 993 1.1× 498 1.1× 194 0.5× 272 0.9× 300 1.1× 13 1.7k

Countries citing papers authored by Annabel Acs

Since Specialization
Citations

This map shows the geographic impact of Annabel Acs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabel Acs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabel Acs more than expected).

Fields of papers citing papers by Annabel Acs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabel Acs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabel Acs. The network helps show where Annabel Acs may publish in the future.

Co-authorship network of co-authors of Annabel Acs

This figure shows the co-authorship network connecting the top 25 collaborators of Annabel Acs. A scholar is included among the top collaborators of Annabel Acs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabel Acs. Annabel Acs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chubb, Barrie, Annabel Acs, Akanksha Verma, et al.. (2023). Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide. Journal of Medical Economics. 26(1). 1019–1031. 1 indexed citations
2.
Fenu, Elisabetta, et al.. (2022). Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada. PharmacoEconomics - Open. 6(4). 519–537. 6 indexed citations
3.
4.
Zhao, Yang, et al.. (2019). <p>Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye</p>. Clinical ophthalmology. Volume 13. 2285–2292. 34 indexed citations
5.
Acs, Annabel, Kyu Rhee, Talia Boulanger, et al.. (2019). Effect of Organization-Directed Workplace Interventions on Physician Burnout: A Systematic Review. SHILAP Revista de lepidopterología. 3(4). 384–408. 120 indexed citations
6.
Einarson, Thomas R., et al.. (2018). Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular Diabetology. 17(1). 83–83. 1423 indexed citations breakdown →
7.
Einarson, Thomas R., et al.. (2018). Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review. Value in Health. 21(7). 881–890. 193 indexed citations
8.
Acs, Annabel, et al.. (2017). Prevalence of Cardiovascular Disease In Type 2 Diabetes: A Global Systematic Review. Value in Health. 20(9). A475–A475. 8 indexed citations
9.
Einarson, Thomas R., et al.. (2016). COST EFFECTIVENESS OF SCREENING FOR TYPE 2 DIABETES MELLITUS AND PRE-DIABETES: SYSTEMATIC LITERATURE REVIEW. Value in Health. 19(3). A302–A302.
10.
Einarson, Thomas R., et al.. (2016). Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetes. Current Medical Research and Opinion. 33(2). 331–358. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrik Haagen Panton Breakdown of academic impact, for papers by Frank Schäper Breakdown of academic impact, for papers by Sandra Pinho Silveiro Breakdown of academic impact, for papers by Dong Zhao Breakdown of academic impact, for papers by Dudan Zhang Breakdown of academic impact, for papers by Angelyne Amos Breakdown of academic impact, for papers by Chul Sik Kim Breakdown of academic impact, for papers by György Jermendy Breakdown of academic impact, for papers by Eric S. H. Lau Breakdown of academic impact, for papers by Ken Gu
Rankless by CCL
2026